Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GNOSPV-01 by Geneos Therapeutics for Hormone-Sensitive Prostate Cancer: Likelihood of Approval
GNOSPV-01 is under clinical development by Geneos Therapeutics and currently in Phase I for Hormone-Sensitive Prostate Cancer. According to GlobalData,...